MGMarianne Graninger

Marianne Graninger

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Marianne Graninger has a total of 57 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Impaired control of autoimmunity increases pediatric multiple sclerosis risk in EBNA-1-seropositives and -seronegatives

    by Hannes Vietzen, Emmanuelle L. Waubant, T. Charles Casper, Leslie A. Benson, Tanuja Chitnis, Teri Schreiner, Amy T. Waldman, Soe Mar, Bianca Weinstock-Guttman, Laura M. Kühner, et al.

    Multiple sclerosis (MS) is an autoinflammatory disease of the central nervous system (CNS). Epstein–Barr virus (EBV) encodes for EBNA-1 381-452 , which induces autoreactive immune responses against distinct CNS derived proteins (GlialCAM 370-389 , CRYAB 2-21 , MBP 205-224 , ANO2 135-154 ). Although EBV infection is considered essential for MS development, CNS-specific autoimmune responses may also be present in putatively EBV EBNA-1-seronegative patients, warranting further investigation. We studied 548 EBV EBNA-1 seropositive and 30 EBV EBNA-1 seronegative pediatric-onset MS (POMS) patients, along with 578 matched controls. CNS specific antibodies were significantly more prevalent in EBV EBNA-1 seropositive POMS patients (92.2%) than in EBV EBNA-1 seropositive controls (56.3%, P < 0.0001). However, high CNS specific antibody levels were also found in 56.6% of EBV EBNA-1 seronegative POMS patients and 17.4% of EBV EBNA-1 seronegative controls. These findings suggest that while EBV infection amplifies CNS specific autoimmune responses, high-level CNS autoreactive autoimmune responses can also occur independently of EBV EBNA-1. We further evaluated why only some individuals with high-level CNS autoreactive antibody titers develop MS. Mechanistically, we demonstrate that autoreactive immune responses are effectively controlled by NKG2C + and NKG2D + natural killer (NK) cells. These findings indicate that CNS-specific autoimmunity and impaired NK cell regulation, rather than EBV alone, are central to MS risk.

  • Open Access

    Herpesvirus-host interactions in neurological diseases: the immunogenetic role of HLA-E

    by Marianne Graninger, Elisabeth Puchhammer-Stöckl, Hannes Vietzen

    Human herpesviruses (HHVs) comprise nine pathogenic members, including herpes simplex virus 1, herpes simplex virus 2, varicella-zoster virus, Epstein–Barr virus, human cytomegalovirus, human herpesvirus 6A/B, human herpesvirus 7, and Kaposi’s sarcoma-associated herpesvirus. Clinical manifestations of HHV infection can range from asymptomatic cases to a broad spectrum of neurological complications, spanning from acute conditions such as encephalitis to chronic disorders including Alzheimer’s disease and multiple sclerosis. By establishing latency and undergoing repeated reactivation, HHVs maintain lifelong interactions with the human immune system and shape host immune responses, exerting considerable impact on nervous system homeostasis. Individual susceptibility to, and outcomes of, HHV-associated neurological disorders depend on multiple factors, including the infecting HHV strain and host genetics. Recent evidence highlights the pivotal role of the human leukocyte antigen E (HLA-E) pathway—a non-classical major histocompatibility complex class I molecule with immunomodulatory functions—in regulating virus–host interactions. Since some HHVs manipulate HLA-E to evade immune recognition, individual variability in this axis may influence neurological outcomes. In this review, we summarize and discuss current knowledge of the role of HLA-E in herpesvirus-associated neurological diseases.


  • Open Access

    Distinct NK Cell Genetic Variants Are Associated With HSV‐2 Versus VZV Infection of the CNS

    by Marianne Graninger, Laura Maria Kühner, Sarah Maria Berger, Hannes Vietzen, Elisabeth Puchhammer‐Stöckl

    Human alphaherpesvirus infections may cause life‐threatening CNS disease. As NK cell responses are crucial for herpesvirus control, we assessed if specific human genetic variants with influence on host NK cell functions are associated with HSV‐2 or VZV CNS disease development. We included patients with confirmed CNS disease due to HSV‐2 ( n = 25) and VZV infection ( n = 39), and compared them to 400 population controls. The NK cell‐related human genetic variants HLA‐E * 0101/0103 , rs9916629 C/T, NKG2C wt/del, FcγRIIIa 158‐F/V were assessed in all cohorts. HLA‐E‐binding peptide sequences were assessed in the HSV‐2 and VZV reference sequences by NCBI BLAST and peptide prediction. In patients with HSV‐2‐related CNS disease, we observed a significantly increased frequency of the rs9916629 CC variant (32%) and the NKG2C del/del genotype (12%) compared to controls (8% and 1%; p = < 0.0001 and p = 0.0006, respectively), and these variants were identified as independent risk factors for HSV‐2 CNS disease. In contrast, VZV CNS patients showed a higher prevalence of the FcγRIIIa 158‐F/F variant (59%) than controls (34%; p = 0.006). Our results indicate that distinct NK cell pathways are affected in HSV‐2 and VZV CNS disease, respectively, and hint towards differences in genetic predispositions to HSV‐2 versus VZV CNS infection.


  • Open Access

    Association Between NK Cell Genetic Variants and the Development of Long COVID Associated‐ and Prepandemic Small Fiber Neuropathy

    by Marianne Graninger, Verena Endmayr, Laura M. Kühner, Sarah M. Berger, Paulus Rommer, Sigrid Klotz, Ellen Gelpi, Hannes Vietzen, Romana Höftberger, Elisabeth Puchhammer‐Stöckl

    Long coronavirus disease 2019 (COVID) (LC) symptoms including pain and autonomic dysfunction are in some patients associated with small‐fiber neuropathy (SFN). The pathomechanisms underlying SFN are mostly unclear. Natural killer (NK) cells play a crucial role in immune regulation, viral clearance and nerve metabolism. The aim of this study was to identify associations between development of small‐fiber dysfunction dependent and independent of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection, and human genetic markers associated with specific NK cell functions. The genetic markers assessed in all cohorts included: FCGR3A, IGHG1, HLA‐E, NKG2C, and rs9916629. Genotyping was performed using TaqMan assays, Sanger sequencing and touchdown polymerase chain reaction. We assessed human cytomegalovirus (HCMV) IgG serostatus in all participants, and screened for anti‐neuronal, anti‐glial and anti‐ganglioside autoantibodies in both patient cohorts. We included 50 LC patients with newly‐emerged symptoms of small‐fiber dysfunction after SARS‐CoV‐2 infection, 27 prepandemic SFN patients and 320 control persons. Markers associated with low NKG2C response, that is, deletion of the NKG2C gene and lack of prior HCMV infection (IgG seronegativity), occurred significantly more frequently in prepandemic SFN patients compared to LC patients and controls (p = 0.0109 and 0.0005, respectively). In conclusion, markers of impaired NKG2C pathways are associated with prepandemic SFN, but not with Long COVID‐associated small‐fiber dysfunction.


  • Open Access

    Association between human genetic variants affecting the host NK cell response and the development of herpes simplex virus type 1 encephalitis

    by Marianne Graninger, Hannes Vietzen, Elisabeth Puchhammer‐Stöckl

    Herpes simplex virus encephalitis (HSE) is a rare complication of herpes simplex virus type 1 (HSV‐1) infection or reactivation. It is so far unclear why only few patients develop HSE. As natural killer (NK) cells provide an important defense against HSV‐1, we investigated whether there is an association between distinct human genetic variants associated with the host NK cell response and HSE. Forty‐nine adult patients with confirmed HSE and 247 matched controls were analyzed for the distribution of the following genotypes: CD16A (FcγRIIIA) V/F and IGHG1 G1m3/17, both influencing antibody‐dependent cellular cytotoxicity; HLA‐E*0101/*0103, associated with NK cell activation; and SLFN13 rs9916629C/T associated with NK cell response. Homozygous HLA‐E*0101:0101 and HLA‐E*0103:0103 variants as well as the rs9916629CC genotype were overrepresented in HSE patients compared to controls (p ≤ 0.001). Notably, cooccurrence of the homozygous HLA‐E*0101 and rs9916629CC genotypes was present in 19% of patients but totally absent in controls (p ≤ 0.0001). Distribution of CD16A and IGHG1 variants did not differ between patients and controls. Our data show that the rare combination of HLA‐E*0101:0101 and rs9916629CC is significantly associated with HSE. Possibly, these genetic variations could be useful as clinical markers predicting HSE prognosis and helping to adapt the treatment of HSE in the individual patient.


  • Open Access

    Comprehensive Comparison of Seven SARS-CoV-2-Specific Surrogate Virus Neutralization and Anti-Spike IgG Antibody Assays Using a Live-Virus Neutralization Assay as a Reference

    by Marianne Graninger, Claudia Maria Jani, Elisabeth Reuberger, Katja Prüger, Philipp Gaspar, David Niklas Springer, Christian Borsodi, Lisa Weidner, Susanne Rabady, Elisabeth Puchhammer-Stöckl, et al.

    While the measurement of neutralizing antibodies is considered a valuable tool in assessing protection against SARS-CoV-2, neutralization tests employ live-virus isolates and cell culture, requiring advanced laboratory biosafety levels. Including a large sample panel (over 700 samples), this study provides adapted cutoff values calculated for seven commercial immunoassays (including four surrogate neutralization assays and a protein-based microarray) that robustly correlate with specific titers of neutralizing antibodies.


  • Open Access

    Association between Epstein‐Barr‐Virus reactivation and development of Long‐COVID fatigue

    by Johanna Rohrhofer, Marianne Graninger, Lisa Lettenmaier, Johannes Schweighardt, Salvatore Alessio Gentile, Larissa Koidl, Davide Ret, Michael Stingl, Elisabeth Puchhammer‐Stöckl, Eva Untersmayr